Screener
iRadimed IRMD Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $21,979 | $19,511 |
| Cost of revenue | 5,165 | 4,668 |
| Gross profit | 16,814 | 14,843 |
| Operating expenses: | ||
| General and administrative | 4,569 | 4,611 |
| Sales and marketing | 4,052 | 4,176 |
| Research and development | 956 | 624 |
| Total operating expenses | 9,577 | 9,411 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's total cost of revenue?
- iRadimed (IRMD) reported total cost of revenue of $5.17M in Q1 2026.
- How has iRadimed's total cost of revenue changed year-over-year?
- iRadimed's total cost of revenue increased by 10.6% year-over-year, from $4.67M to $5.17M.
- What is the long-term trend for iRadimed's total cost of revenue?
- Over 4 years (2021 to 2025), iRadimed's total cost of revenue has grown at a 18.9% compound annual growth rate (CAGR), from $9.76M to $19.49M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about iRadimed's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude